LEFLUNOMIDE SZ leflunomide 100mg tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

leflunomide, Quantity: 100 mg

MAH:

Southern Cross Pharma Pty Ltd

INN:

Leflunomide

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: microcrystalline cellulose; povidone; colloidal anhydrous silica; crospovidone; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000

administration_route:

Oral

units_in_package:

3 tablet

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Treatment of active rheumatoid arthritis. The combined use of leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

leaflet_short:

Visual Identification: White, oblong biconvex tablets with a scoreline on one side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2014-04-02